Díaz SC, Turcios TSE, Robles TE, García GY

Language: Spanish
References: 11
Page: 198-205
PDF size: 126.02 Kb.

ABSTRACT

Glucocorticoid deprivation syndrome occurs in patients with endogenous hypercortisolism after surgery and in individuals receiving treatments at high doses of glucocorticoids for more than 2 weeks. The hypothalamus-hypophysisadrenocortical axis regulates the daily cortisol secretion and presents a Circadian rhythm that may be affected by stress, disease or glucocorticoid administration The corticoid withdrawal may cause secondary adrenal insufficiency, corticoid deprivation or withdrawal syndrome and reactivation of the underlying disease for which they were prescribed. The secondary adrenal insufficiency is currently the most serious complication and the main reason for adrenal crisis and secondary adrenal insufficiency. The corticoid deprivation or withdrawal syndrome is selflimited and may be easily treated with temporary increase of the corticoid dose, followed by slow withdrawal of this agent. It is then necessary to find out the advantages and limitations of the glucocorticosteroid treatment and its gradual cessation. The state of the hypothalamus-hypophysis-adrenocortical axis should be adequately evaluated at the end of a long treatment, or with the use of supraphysiological doses of glucocorticoids.

REFERENCES

1. Hernández JA, Jorge R. Trastornos de la glándula hipofisaria. La Habana: Editorial Ciencias Médicas; 2010. p. 54-6.

2. Botargues M, Enz P, Musso C. Tratamiento con corticoides. Evid Act Pract Ambul. 2011;14(1):33-6.

3. Chung S, Gi S, Kyungjin K. Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2011;(1812.5):581-91.

4. Galofré J. Manejo de los corticoides en la práctica clínica. Rev Med Univ Navarra. 2009;53(1):9-18.

5. Serra HA, Roganovich JM, Rizzo LF. Glucocorticoides: de lo molecular al uso clínico. MEDICINA (Buenos Aires). 2012;72:158-70.

6. Alves C, Robazzi TC, Mendonça M. Withdrawal from glucocorticosteroid therapy: clinical practice recommendations. J Pediatr (Rio J). 2008;84(3):192-202.

7. Rica I, Grau G, Vela A. Insuficiencia suprarrenal. Protoc Diagn Ter Pediatr. 2011;1:166-76.

8. Pérez Corral B, Aguado Matilla R, Álvarez San Martín RM, Ballesteros Pomar MD, Roiz V, Cano Rodríguez I. Síndrome de supresión de corticoides. Endocrinol Nutr. 2007;54(7):395-7.

9. Casado-Verrier B, Sanz-Canalejas L, Gómez-Fernández C, Pagán B, López M, Casado-Jiménez M. Síndrome de Cushing iatrogénico por corticoides tópicos en dos adultos. Med Cutan Iber Lat Am. 2012;40(2):58-61.

10. Alejandre Lázaro G, Moreno García F. Corticosteroides tópicos. Inf Ter Sist Nac Salud. 2010;34:83-8.

11. Izquierdo Alonso JL, Rodríguez Glez-Moro JM. Utilización excesiva de corticoides inhalados en la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol. 2012;48(6):207-12.